Bridge Creek Capital Management LLC Acquires 285 Shares of Teleflex Incorporated (NYSE:TFX)

Bridge Creek Capital Management LLC grew its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 1.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 16,730 shares of the medical technology company’s stock after acquiring an additional 285 shares during the quarter. Bridge Creek Capital Management LLC’s holdings in Teleflex were worth $2,978,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Acadian Asset Management LLC raised its position in Teleflex by 84.7% in the second quarter. Acadian Asset Management LLC now owns 399 shares of the medical technology company’s stock valued at $83,000 after purchasing an additional 183 shares during the last quarter. Choreo LLC bought a new position in Teleflex in the 2nd quarter valued at approximately $220,000. Royal London Asset Management Ltd. boosted its position in Teleflex by 1.8% during the 2nd quarter. Royal London Asset Management Ltd. now owns 18,809 shares of the medical technology company’s stock worth $3,956,000 after buying an additional 334 shares during the period. American Century Companies Inc. grew its holdings in Teleflex by 4.6% during the 2nd quarter. American Century Companies Inc. now owns 9,509 shares of the medical technology company’s stock worth $2,000,000 after acquiring an additional 420 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale increased its position in Teleflex by 1,388.6% in the 2nd quarter. DekaBank Deutsche Girozentrale now owns 108,516 shares of the medical technology company’s stock valued at $22,331,000 after acquiring an additional 101,226 shares during the period. Institutional investors own 95.62% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on TFX. StockNews.com raised shares of Teleflex from a “hold” rating to a “buy” rating in a research note on Thursday, November 28th. Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. Mizuho cut their price objective on Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a research note on Friday, November 1st. Royal Bank of Canada reduced their target price on Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a report on Friday, November 1st. Finally, Truist Financial lowered their price target on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a report on Wednesday, December 18th. Three analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat, Teleflex presently has an average rating of “Moderate Buy” and an average price target of $252.50.

Teleflex Trading Up 2.3 %

Shares of Teleflex stock traded up $4.06 on Monday, reaching $178.67. 268,389 shares of the company’s stock were exchanged, compared to its average volume of 442,719. The firm’s 50-day moving average is $186.33 and its two-hundred day moving average is $216.58. The company has a market capitalization of $8.30 billion, a P/E ratio of 35.52, a price-to-earnings-growth ratio of 1.84 and a beta of 1.16. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. Teleflex Incorporated has a 52 week low of $171.69 and a 52 week high of $256.85.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 earnings per share for the quarter, beating the consensus estimate of $3.38 by $0.11. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The firm had revenue of $764.40 million for the quarter, compared to analyst estimates of $768.68 million. During the same quarter in the prior year, the business earned $3.64 earnings per share. The business’s quarterly revenue was up 2.4% compared to the same quarter last year. Sell-side analysts predict that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, December 16th. Stockholders of record on Friday, November 15th were given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.76%. The ex-dividend date was Friday, November 15th. Teleflex’s payout ratio is 27.04%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.